GAMCO Investors’s Evolent Health EVH Stock Holding History

GAMCO Investors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$660K	Buy	289,500 +12,000	+4%	+$38.1K	0.01%	708
2025 Q4	$1.11M	Buy	277,500 +33,500	+14%	+$186K	0.01%	633
2025 Q3	$2.06M	Sell	244,000 -1,200	-0.5%	-$11.6K	0.02%	518
2025 Q2	$2.76M	Sell	245,200 -2,300	-0.9%	-$21.1K	0.03%	477
2025 Q1	$2.34M	Buy	247,500 +50,400	+26%	+$509K	0.03%	466
2024 Q4	$2.22M	Buy	197,100 +60,000	+44%	+$1.05M	0.02%	486
2024 Q3	$3.88M	Buy	137,100 +5,300	+4%	+$137K	0.04%	378
2024 Q2	$2.52M	Buy	131,800 +34,800	+36%	+$889K	0.03%	460
2024 Q1	$3.18M	Hold	97,000	–	–	0.03%	415
2023 Q4	$3.2M	Hold	97,000	–	–	0.03%	406
2023 Q3	$2.64M	Buy	97,000 +500	+0.5%	+$13.9K	0.03%	429
2023 Q2	$2.92M	Hold	96,500	–	–	0.03%	419
2023 Q1	$3.13M	Hold	96,500	–	–	0.03%	399
2022 Q4	$2.71M	Hold	96,500	–	–	0.03%	413
2022 Q3	$3.47M	Sell	96,500 -3,400	-3%	-$120K	0.04%	370
2022 Q2	$3.07M	Sell	99,900 -4,600	-4%	-$134K	0.03%	395
2022 Q1	$3.38M	Sell	104,500 -2,000	-2%	-$52.4K	0.03%	407
2021 Q4	$2.95M	Hold	106,500	–	–	0.03%	443
2021 Q3	$3.3M	Sell	106,500 -16,500	-13%	-$396K	0.03%	426
2021 Q2	$2.6M	Hold	123,000	–	–	0.02%	472
2021 Q1	$2.48M	Sell	123,000 -16,000	-12%	-$304K	0.02%	470
2020 Q4	$2.23M	Sell	139,000 -16,000	-10%	-$211K	0.02%	462
2020 Q3	$1.92M	Sell	155,000 -4,000	-3%	-$47K	0.02%	465
2020 Q2	$1.13M	Sell	159,000 -154,003	-49%	-$1.03M	0.01%	544
2020 Q1	$1.7M	Hold	313,003	–	–	0.02%	462
2019 Q4	$2.83M	Buy	313,003 +35,000	+13%	+$284K	0.02%	445
2019 Q3	$2M	Buy	278,003 +34,000	+14%	+$244K	0.02%	492
2019 Q2	$1.94M	Buy	244,003 +21,600	+10%	+$256K	0.01%	507
2019 Q1	$2.8M	Buy	222,403 +39,500	+22%	+$625K	0.02%	442
2018 Q4	$3.65M	Buy	182,903 +10,500	+6%	+$243K	0.03%	376
2018 Q3	$4.9M	Sell	172,403 -9,700	-5%	-$231K	0.03%	365
2018 Q2	$3.83M	Buy	182,103 +100	+0.1%	+$1.89K	0.03%	392
2018 Q1	$2.59M	Buy	182,003 +16,000	+10%	+$229K	0.02%	436
2017 Q4	$2.04M	Buy	166,003 +91,000	+121%	+$1.28M	0.01%	485
2017 Q3	$1.33M	Buy	+75,003	New	+$1.55M	0.01%	540

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAMCO Investors's EVH Position: Q1 2026 in Review

GAMCO Investors increased its Evolent Health (EVH) stake by 4.3% in Q1 2026, buying an estimated $38.1K and bringing the position to 289,500 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #708.

GAMCO Investors first reported a position in EVH in Q3 2017 and has held it in 35 quarters since. The position peaked at $4.9M in Q3 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

GAMCO Investors held 289,500 shares of Evolent Health worth $660K as of Q1 2026.
GAMCO Investors bought 12,000 Evolent Health shares in Q1 2026, an estimated $38.1K.
Evolent Health made up 0.01% of GAMCO Investors's portfolio in Q1 2026, its #708 holding.
GAMCO Investors first reported a position in Evolent Health in Q3 2017 and has held it in 35 quarters since.
GAMCO Investors's Evolent Health position peaked at $4.9M in Q3 2018.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.